Optimizing Integrated PMTCT Services in Rural North-Central Nigeria
NCT01805752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 369
Last updated 2016-11-02
Summary
Each year, an estimated 230,000 HIV-infected women in need of services for prevention of mother-to-child transmission of HIV (PMTCT) give birth in Nigeria, more than in any other nation in the world. Vanderbilt University (VU), through its affiliate, Friends in Global Health (FGH), is currently supporting HIV/AIDS services in North-Central Nigeria. These sites are predominantly rural primary health centers (PHCs) where shortages of high-cadre health care providers and insufficient laboratory capacity to perform CD4+ cell count testing have been major barriers to effective PMTCT scale-up. A systematic reassignment of patient care responsibilities coupled with the adoption of point-of-care (POC) CD4+ cell count testing will facilitate the ability of lower-cadre health providers to manage PMTCT care, including the provision and scale-up of antiretroviral treatment (ART) to pregnant women in these rural, decentralized sites. A system wherein men are facilitated to accompany their wives to ANC appointments will create an important opportunity to address entrenched gender norms. The investigators therefore propose using community and facility-based measures to encourage male partners to accompany their spouses for ANC. As influential community members, male partners can assist their spouses to utilize culturally-sensitive, sustainable and integrated PMTCT care provided by lower-cadre providers in these resource-constrained settings.
The investigators propose a parallel, cluster randomized trial to evaluate the impact of a family-focused PMTCT package that includes: 1) task-shifting to lower-cadre providers at PMTCT sites; 2) POC CD4+ cell count testing; (3) integrated mother-infant care; and (4)) a prominent role for influential family members (male partners), working in close partnership with community-based health workers/volunteers. The specific aims of this study are:
1. To evaluate whether implementation of the integrated PMTCT package in primary level antenatal clinics (ANC) increases the proportion of eligible pregnant women who initiate antiretroviral medications for the purposes of PMTCT. The investigators hypothesize that the provision of the PMTCT package in intervention clinics will improve PMTCT antiretroviral uptake rates among eligible women during pregnancy from 40% to 65%.
2. To determine whether implementation of the PMTCT package improves postpartum retention of mother-infant pairs at 6 and 12 weeks. The investigators hypothesize that postpartum retention rates among mother-infant pairs attending intervention sites will be \>20% higher at 6 weeks when compared to mother-infant pairs receiving care in non-intervention sites.
3. Conduct a cost-effectiveness analysis (CEA) of the impact of this novel PMTCT intervention compared to the existing standard-of-care referral model. The investigators hypothesize that the proposed intervention will be more cost-effective than the existing model of care.
In addition, two qualitative evaluations will be conducted in order to:
1. Assess client satisfaction with health services, comparing PMTCT services provided by lower level vs. higher level cadre health workers; and
2. Evaluate health care worker satisfaction with the new PMTCT service delivery model.
Conditions
- Suspected Damage to Fetus From Viral Disease in the Mother
- HIV
Interventions
- OTHER
-
Task-shifting to lower-cadre providers at PMTCT sites
- OTHER
-
POC CD4+ cell count testing
- OTHER
-
integrated mother-infant care
- OTHER
-
Prominent role for influential family members (male partners) in collaboration with CHWs
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Vanderbilt University
lead OTHER
Principal Investigators
-
Muktar H Aliyu, MBBS, DrPH · Vanderbilt University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-06-30
Countries
- Nigeria
- Niger
Study Locations
More Related Trials
-
Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth
NCT01647841 ·Status: COMPLETED
-
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
NCT06999928 ·Status: RECRUITING ·Phase: NA
-
Preventing Unplanned Pregnancies in HIV Infected Zambian Couples
NCT00067522 ·Status: UNKNOWN ·Phase: NA
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe
NCT04206241 ·Status: COMPLETED
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
NCT01645865 ·Status: COMPLETED
-
Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns
NCT05017558 ·Status: UNKNOWN
-
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
NCT01836003 ·Status: COMPLETED ·Phase: NA
-
Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
NCT01933477 ·Status: COMPLETED ·Phase: NA
-
Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?
NCT02070900 ·Status: UNKNOWN ·Phase: NA
-
Botswana Diarrheal Diseases Study
NCT00197652 ·Status: COMPLETED
-
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies
NCT00120471 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of an Early Childhood Development Intervention Among Children Born to HIV-Infected Women in Eswatini
NCT04114305 ·Status: COMPLETED
-
Cash Transfers to Pregnant Women With HIV
NCT07226492 ·Status: RECRUITING ·Phase: NA
-
Healthy Beginning Initiative
NCT01795261 ·Status: UNKNOWN
-
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 ·Status: COMPLETED
-
Impact of Point-of-care (POC) Viral Load (VL) Testing During Pregnancy in Zimbabwe
NCT04048629 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPA
NCT03153709 ·Status: COMPLETED
-
HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy
NCT00393302 ·Status: COMPLETED
-
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
NCT06267508 ·Status: RECRUITING
-
Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers
NCT00164762 ·Status: COMPLETED
-
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
NCT00334256 ·Status: COMPLETED ·Phase: PHASE2